You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pf-02341066

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC ALK-positive, NSCLC c-Met Dependent, NSCLC ROS Marker Positive Trial in Worldwide (PF-02341066, Rifampin, Itraconazole)

Completed
Has Results
  • Non-Small Cell Lung Cancer ALK-positive
  • +4 more
  • PF-02341066
  • +2 more
  • Orange, California
  • +28 more
Feb 15, 2022

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • PF-02341066
  • +2 more
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • PF-02341066
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • PF-02341066
  • +2 more
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

Non Small Cell Lung Cancer Trial in Australia, United States (PF-02341066, PF-00299804)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Aurora, Colorado
  • +9 more
Oct 6, 2015

NSCLC Trial in United States (Erlotinib, PF-02341066)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Birmingham, Alabama
  • +15 more
Oct 6, 2015

Healthy Volunteer Trial in New Haven (PF-02341066)

Completed
Has Results
  • Healthy Volunteer
  • PF-02341066
  • New Haven, Connecticut
    Pfizer Investigational Site
Feb 28, 2012

Healthy Trial in Hachioji-shi (PF-02341066)

Completed
Has Results
  • Healthy
  • PF-02341066
  • Hachioji-shi, Tokyo, Japan
    Pfizer Investigational Site
Oct 20, 2011

Healthy Trial in New Haven (PF-02341066)

Completed
Has Results
  • Healthy
  • PF-02341066
  • New Haven, Connecticut
    Pfizer Investigational Site
Oct 20, 2011